Involvement of human papillomavirus in upper aero-digestive tracts cancers;Implication des papillomavirus humains dans les cancers des voies aérodigestives supérieures

Bulletin du Cancer

Volumn 96, Issue 10, 2009, Pages 941-950

  Ernoux NeufCoeur, P ^a   Arafa, M ^b   Delvenne, P ^b   Saussez, S ^a  

^a UNIVERSITY OF MONS   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Cancers; HPV; Oropharynx; p53; pRB; Upper aero digestives tracts

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P53; WART VIRUS VACCINE;

DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DNA TUMOR VIRUS; HEAD AND NECK CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; INCIDENCE; PROGNOSIS; REVIEW; SEXUALLY TRANSMITTED DISEASE; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TONSIL CARCINOMA; WART VIRUS; FEMALE; GENETICS; HEAD AND NECK TUMOR; LARYNX TUMOR; MALE; MOUTH TUMOR; NOSE TUMOR; PAPILLOMA VIRUS; PHARYNX CANCER; PHYSIOLOGY; PREVALENCE; SALIVARY GLAND TUMOR; SEXUAL BEHAVIOR; VIROLOGY; VIRUS DNA CELL DNA INTERACTION; VIRUS INFECTION;

CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; LARYNGEAL NEOPLASMS; MALE; MOUTH NEOPLASMS; NOSE NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHARYNGEAL NEOPLASMS; PREVALENCE; PROGNOSIS; SALIVARY GLAND NEOPLASMS; SEXUAL BEHAVIOR; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; VIRUS INTEGRATION;

EID: 70350488933     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2009.0923     Document Type: Review

References (31)

1. Ragin CC, Modugno F, Gollin SM. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res 2007 ; 86 : 104-114
2. Castellsagué X. Natural history of HPV infection and cervical cancer. Gynecologic Oncology 2008 ; 110 : 4-7.
3. Doorbar J. The papillomavirus life cycle. J Clin Virol 2005 ; 32 : 7-15.
4. Psyrri A, DiMaio D. Human papillomavirus in cervical and head-and-neck cancer. Oncology 2008 ; 5 : 24-31.
5. Munoz N, Bosch FX, Castellsague X, Diaz M, De Sanjosé S, Hammouda D, et al. Against which papillomavirus shall we vaccinate and screen? The international perspective. Int J Cancer 2004 ; 111 : 278-285 (Pubitemid 38924707)
6. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human Papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005 ; 14 : 467-475 (Pubitemid 40270113)
7. Kjaer SK, Chackerian B, Van den Brule AJ, Svare EI, Paull G, Walbomers JM, et al. HR-HPV is sexually transmitted: evidence for a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001 ; 10 : 101-106 (Pubitemid 32172427)
8. Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Infect Dis 2006 ; 6 : 21-31. (Pubitemid 41831374)
9. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 2006 ; 194 : 1044-1057 (Pubitemid 44547644)
10. De Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, et al. Worldwide prevalence and genotype distribution of cervical HPV DNA in women with normal cytology: a meta analysis. Lancet Infect Dis 2007 ; 7 : 453-459
11. Delvenne P, Hubert P, Jacobs N. Epithelial metaplasia: an inadequate environment for antitumour immunity? Trends Immunol 2004 ; 25 : 169-173
12. Nguyen CL, Münger K. Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes. Virology 2008 ; 380 : 21-25
13. Applebaum KM, Furniss CS, Zeka A, Posner MR, Smith JF, Bryan J, et al. Lack of association of alcohol and Tobacco with HPV16 associated Head and Neck Cancer. J Natl Cancer Inst 2007 ; 99 : 1801-1810 (Pubitemid 351767210)
14. Syrjänen S. Human papillomavirus (HPV) in head and neck carcinomas. J Clin Virol 2005 ; 32 : 55-66. (Pubitemid 40332590)
15. Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer. Epidemiology consortium. J Natl Cancer Inst 2007 ; 99 : 777-789
16. Sturgis E, Cinciripini PM. Trends in head and neck cancer Incidence in relation to smoking prevalence. An emerging epidemic of human papillomavirus-associated cancers? Cancer 2007 ; 110 : 1429-1435
17. Gillison ML, Wayne M, Rondolp B, Spafford M, Westra WH, Wu L, et al. Evidence for causal association between human papillomavirus and subset of head and Neck cancer. J Natl Cancer Inst 2000 ; 92 : 709-720 (Pubitemid 30365531)
18. Portugal LG, Goldenberg JD, Wenig BL, Posner M, Liu M, Kelsey KT. Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1997 ; 123 : 1230-1234 (Pubitemid 27481587)
19. Herrero R, Castellsagué X, Pawlita M, Lissowska J, Kee F, Balaram P, et al. Human papillomavirus and oral cancer: the international agency for research on cancer multicenter study. J Natl Cancer Inst 2003 ; 95 : 1772-1783 (Pubitemid 38008900)
20. Ringstöm E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002 ; 8 : 3187-3192 (Pubitemid 35155029)
21. Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Eckel HE, Pfister HJ, et al. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? Med Microbiol Immunol 2003 ; 192 : 129-132
22. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancer. J Natl Cancer Inst 2008 ; 100 : 407-420
23. Dahlstrand H, Näsman A, Romanitan M, Lindquist D, Ramqvist T, Dalianis T. Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer. Anticancer Res 2008 ; 28 : 1133-1138 (Pubitemid 351578850)
24. Begum S, Cao D, Gillison M, Zahurak M, Westra WH. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 2005 ; 11 : 5694-5699 (Pubitemid 41170292)
25. Li W, Thompson CH, Cossart YE. The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head Neck 2004 ; 26 : 1-9. (Pubitemid 38030143)
26. Kreimer AR, Alberg AJ, Daniel R, Gravitt PE, Viscidi R, Garrett ES, et al. Oral human papillomavirus infection in adults is associated with sexual behaviour and HIV serostatus. J Infect Dis 2004 ; 189 : 686-698 (Pubitemid 38270923)
27. Smith EM, Wang D, Rubenstein LM, Morris WA, Turek LP, Haugen TH. Association between p53 and human papillomavirus in head and neck cancer. Cancer Epidemiol Biomarkers Prev 2008 ; 17 : 421-427 (Pubitemid 351272796)
28. Weinberger PW, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, et al. Molecular classification identifies a subset of human papillomavirus- associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006 ; 24 : 736-747 (Pubitemid 46622040)
29. Van der Riet P, Nawroz H, Hruban RH, Corio R, Tokino K, Koch W, et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 1996 ; 56 : 2488-2492 (Pubitemid 24108049)
30. Smith EM, Wang D, Kim Y, Rubenstein LM, Lee JH, Haugen TH, et al. p16INK4A expression, human papillomavirus, and survival in head and neck cancer. Oral Oncol 2008 ; 44 : 133-142 (Pubitemid 351179656)
31. Cojocariu O, Huguet F, Lefevre M, Périé S. Prognosis and predictive factors in head-and-neck cancers. Bull Cancer 2009 ; 96 : 369-378